The effects of statins on insulin secretion and the stimulus-secretion coupling of the beta cells are uncertain, but in the Metabolic Syndrome in Men (METSIM) cohort [10, 11] statins, including rosuvastatin, reduce insulin secretion. This evidence concerns the gene INS and metabolic syndrome.